Monthly Archives: September 2011

Fosamprenavir – opposition – india

Indian patent journal of this week (Sep 16th, 2011) has a post grant opposition filed under section 25(2). Lupin has filed post grant opposition to 240930 (2210/Cal/1998) under section 25(2)  on June 08, 2011. The ‘930 patent seems to cover Fosamprenavir, is … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , , , , | Leave a comment

Azilsartan medoxomil – opposition – India

Indian patent journal (of September 9th 2011) has some new post grant oppositions filed under section 25(2) of Patent Act 1970. The controller may generally publish such post oppositions filed under section 25(2)in official journal. Ranbaxy, Lupin and MSN have filed post grant opposition … Continue reading

Posted in Daily interesting IP news, Ranbaxy | Tagged , , , , , | 4 Comments

Imatinib India News aggregation

[Business Line] [SC Order] [Money control] In a latest order by SC India, the Novartis imatinib case will be listed “before a Bench of one where Hon’ble Mr. Justice Dalveer Bhandari is not a member“.

Posted in Daily interesting IP news | Tagged , , | Leave a comment